LPTX Message Board Post 9281750 | Leap Therapeutics Inc.
home / stock / lptx / lptx message board
Ecarluccio
(investorshub)
Posted on: Sep/21/2021 22:53:46
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166016787
Share options were executed for $2.77 up to
News, Short Squeeze, Breakout and More Instantly...
-
Leap Therapeutics Announces $40 Million Private Placement PR Newswire Net proceeds, along with existing cash, cash equivalents, and marketable securities are expected to extend cash runway into Q2 2026 and enable expansion of DKN-01 DeFianCe clinical trial and development prog...
-
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire CAMBRIDGE, Mass. , March 18, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeut...
-
Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium PR Newswire 30% ORR and 93% DCR across heterogenous second-line CRC patients treated with DKN-01 plus bevacizumab and chemotherapy ...